BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

627 related articles for article (PubMed ID: 19846409)

  • 1. The lymphatic system controls intestinal inflammation and inflammation-associated Colon Cancer through the chemokine decoy receptor D6.
    Vetrano S; Borroni EM; Sarukhan A; Savino B; Bonecchi R; Correale C; Arena V; Fantini M; Roncalli M; Malesci A; Mantovani A; Locati M; Danese S
    Gut; 2010 Feb; 59(2):197-206. PubMed ID: 19846409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protection against inflammation- and autoantibody-caused fetal loss by the chemokine decoy receptor D6.
    Martinez de la Torre Y; Buracchi C; Borroni EM; Dupor J; Bonecchi R; Nebuloni M; Pasqualini F; Doni A; Lauri E; Agostinis C; Bulla R; Cook DN; Haribabu B; Meroni P; Rukavina D; Vago L; Tedesco F; Vecchi A; Lira SA; Locati M; Mantovani A
    Proc Natl Acad Sci U S A; 2007 Feb; 104(7):2319-24. PubMed ID: 17283337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased inflammation in mice deficient for the chemokine decoy receptor D6.
    Martinez de la Torre Y; Locati M; Buracchi C; Dupor J; Cook DN; Bonecchi R; Nebuloni M; Rukavina D; Vago L; Vecchi A; Lira SA; Mantovani A
    Eur J Immunol; 2005 May; 35(5):1342-6. PubMed ID: 15789340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of the chemokine scavenger receptor D6 in balancing inflammation and immune activation.
    Borroni EM; Buracchi C; Savino B; Pasqualini F; Russo RC; Nebuloni M; Bonecchi R; Mantovani A; Locati M
    Methods Enzymol; 2009; 460():231-43. PubMed ID: 19446728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. VEGF-A links angiogenesis and inflammation in inflammatory bowel disease pathogenesis.
    Scaldaferri F; Vetrano S; Sans M; Arena V; Straface G; Stigliano E; Repici A; Sturm A; Malesci A; Panes J; Yla-Herttuala S; Fiocchi C; Danese S
    Gastroenterology; 2009 Feb; 136(2):585-95.e5. PubMed ID: 19013462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemokine scavenging by D6: a movable feast?
    Graham GJ; McKimmie CS
    Trends Immunol; 2006 Aug; 27(8):381-6. PubMed ID: 16814608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential activation of total and EGF receptor (EGF-R) tyrosine kinase (tyr-k) in the rectal mucosa in patients with adenomatous polyps, ulcerative colitis and colon cancer.
    Malecka-Panas E; Kordek R; Biernat W; Tureaud J; Liberski PP; Majumdar AP
    Hepatogastroenterology; 1997; 44(14):435-40. PubMed ID: 9164515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemokine expression in IBD. Mucosal chemokine expression is unselectively increased in both ulcerative colitis and Crohn's disease.
    Banks C; Bateman A; Payne R; Johnson P; Sheron N
    J Pathol; 2003 Jan; 199(1):28-35. PubMed ID: 12474223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone marrow transplantation ameliorates pathology in interleukin-10 knockout colitic mice.
    Bamba S; Lee CY; Brittan M; Preston SL; Direkze NC; Poulsom R; Alison MR; Wright NA; Otto WR
    J Pathol; 2006 Jun; 209(2):265-73. PubMed ID: 16550633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemokine decoy receptor d6 plays a negative role in human breast cancer.
    Wu FY; Ou ZL; Feng LY; Luo JM; Wang LP; Shen ZZ; Shao ZM
    Mol Cancer Res; 2008 Aug; 6(8):1276-88. PubMed ID: 18708360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inducible nitric oxide synthase from bone marrow-derived cells plays a critical role in regulating colonic inflammation.
    Beck PL; Li Y; Wong J; Chen CW; Keenan CM; Sharkey KA; McCafferty DM
    Gastroenterology; 2007 May; 132(5):1778-90. PubMed ID: 17449036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The atypical chemokine receptor D6 suppresses the development of chemically induced skin tumors.
    Nibbs RJ; Gilchrist DS; King V; Ferra A; Forrow S; Hunter KD; Graham GJ
    J Clin Invest; 2007 Jul; 117(7):1884-92. PubMed ID: 17607362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reactivation of inflammatory bowel disease in a mouse model of depression.
    Ghia JE; Blennerhassett P; Deng Y; Verdu EF; Khan WI; Collins SM
    Gastroenterology; 2009 Jun; 136(7):2280-2288.e1-4. PubMed ID: 19272381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A role for proteinase-activated receptor-1 in inflammatory bowel diseases.
    Vergnolle N; Cellars L; Mencarelli A; Rizzo G; Swaminathan S; Beck P; Steinhoff M; Andrade-Gordon P; Bunnett NW; Hollenberg MD; Wallace JL; Cirino G; Fiorucci S
    J Clin Invest; 2004 Nov; 114(10):1444-56. PubMed ID: 15545995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The NSAID sulindac is chemopreventive in the mouse distal colon but carcinogenic in the proximal colon.
    Mladenova D; Daniel JJ; Dahlstrom JE; Bean E; Gupta R; Pickford R; Currey N; Musgrove EA; Kohonen-Corish MR
    Gut; 2011 Mar; 60(3):350-60. PubMed ID: 20980345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-viral delivery of nuclear factor-kappaB decoy ameliorates murine inflammatory bowel disease and restores tissue homeostasis.
    De Vry CG; Prasad S; Komuves L; Lorenzana C; Parham C; Le T; Adda S; Hoffman J; Kahoud N; Garlapati R; Shyamsundar R; Mai K; Zhang J; Muchamuel T; Dajee M; Schryver B; McEvoy LM; Ehrhardt RO
    Gut; 2007 Apr; 56(4):524-33. PubMed ID: 16950831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inflammatory bowel disease: a model of chronic inflammation-induced cancer.
    Yang GY; Taboada S; Liao J
    Methods Mol Biol; 2009; 511():193-233. PubMed ID: 19347299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CCR6 has a non-redundant role in the development of inflammatory bowel disease.
    Varona R; Cadenas V; Flores J; Martínez-A C; Márquez G
    Eur J Immunol; 2003 Oct; 33(10):2937-46. PubMed ID: 14515278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Essential roles of IL-6 trans-signaling in colonic epithelial cells, induced by the IL-6/soluble-IL-6 receptor derived from lamina propria macrophages, on the development of colitis-associated premalignant cancer in a murine model.
    Matsumoto S; Hara T; Mitsuyama K; Yamamoto M; Tsuruta O; Sata M; Scheller J; Rose-John S; Kado S; Takada T
    J Immunol; 2010 Feb; 184(3):1543-51. PubMed ID: 20042582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of the chemokine decoy receptor D6 is decreased in colon adenocarcinomas.
    Langenes V; Svensson H; Börjesson L; Gustavsson B; Bemark M; Sjöling Å; Quiding-Järbrink M
    Cancer Immunol Immunother; 2013 Nov; 62(11):1687-95. PubMed ID: 24013383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.